back to top

US hails Nigerian doctor for helping to develop Pfizer’s COVID-19 vaccine

THE United States Embassy in Nigeria has hailed and acknowledged Onyema Ogbuagbu, a Nigerian doctor living in the US for his role in the recent Pfizer’s COVID-19 vaccine breakthrough.

According to the Embassy on Monday, Nigerians contribute to the world in so many ways. It saluted Onyema for his incredible contribution to ending this worldwide pandemic.

Onyema, who is an Associate Professor of Medicine and Infectious Diseases at Yale School of Medicine, is one of those leading the Pfizer trial.

He graduated with a medical degree from the University of Calabar, Cross Rivers state in 2003.



Pfizer, an American drug manufacturing company, and the German firm BioNTech, had earlier this month announced a vaccine which suggests it is 90 percent effective at preventing illness.

The companies said they plan to apply for approval from the US authority to use the vaccine by the end of November.




     

     

    They are also projecting to be able to supply 50 million doses by the end of 2020 and around 1.3 billion by the end of 2021.

    Last week, eight American citizens of Nigerian descent were drafted into the professional National Basketball Association (NBA) of the United States.

    The annual draft sees NBA teams choose from the best young talents across the United States.

    The Nigerians are Precious Achiuwa, Udoka Azubuike, Isaac Okoro, Onyeka Okongwu, Daniel Oturu, Zeke Nnaji, Desmond Bane, and Jordan Nwora.

    Read Also:

    You can reach out to me on Twitter via: vincent_ufuoma

    Join the ICIR WhatsApp channel for in-depth reports on the economy, politics and governance, and investigative reports.

    Support the ICIR

    We invite you to support us to continue the work we do.

    Your support will strengthen journalism in Nigeria and help sustain our democracy.

    If you or someone you know has a lead, tip or personal experience about this report, our WhatsApp line is open and confidential for a conversation

    LEAVE A REPLY

    Please enter your comment!
    Please enter your name here


    This site uses Akismet to reduce spam. Learn how your comment data is processed.

    Support the ICIR

    We need your support to produce excellent journalism at all times.

    -Advertisement-

    Recent

    - Advertisement